Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(29 sites)
United States
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama Contra Costa Regional Medical Center, Martinez, California Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Kapiolani Medical Center for Women and Children, Honolulu, Hawaii University of Kansas Cancer Center, Kansas City, Kansas University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas Baptist Health Lexington, Lexington, Kentucky Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan Henry Ford Hospital, Detroit, Michigan Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan The Valley Hospital - Luckow Pavilion, Paramus, New Jersey Valley Health System Ridgewood Campus, Ridgewood, New Jersey University of New Mexico Cancer Center, Albuquerque, New Mexico NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York State University of New York Upstate Medical University, Syracuse, New York CaroMont Regional Medical Center, Gastonia, North Carolina Cone Health Cancer Center, Greensboro, North Carolina Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio Rhode Island Hospital, Providence, Rhode Island McLeod Regional Medical Center, Florence, South Carolina Gibbs Cancer Center-Gaffney, Gaffney, South Carolina Gibbs Cancer Center-Pelham, Greer, South Carolina Spartanburg Medical Center, Spartanburg, South Carolina MGC Hematology Oncology-Union, Union, South Carolina Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas Bon Secours Saint Francis Medical Center, Midlothian, Virginia University of Washington Medical Center - Montlake, Seattle, Washington